Oragenics, Inc. (NYSEAMERICAN:OGEN – Get Free Report)’s stock price dropped 0.3% during mid-day trading on Friday. The stock traded as low as $0.43 and last traded at $0.4349. 32,733 shares traded hands during trading, an increase of 26% from the average session volume of 25,953 shares. The stock had previously closed at $0.4360.
Oragenics Stock Down 0.3%
The stock’s 50-day moving average price is $0.50 and its 200 day moving average price is $0.56. The firm has a market cap of $1.96 million, a price-to-earnings ratio of -0.02 and a beta of 1.26.
Oragenics (NYSEAMERICAN:OGEN – Get Free Report) last released its earnings results on Thursday, August 13th. The company reported ($0.57) earnings per share for the quarter.
Oragenics Company Profile
Oragenics, Inc is a U.S.-based clinical-stage biotechnology company focused on developing intranasal medicines for neurological disorders. Its lead product candidate, ONP-002, is being developed as a potential treatment for concussion and mild traumatic brain injury. The company’s intranasal delivery approach is intended to help deliver therapies directly to the brain while avoiding some limitations associated with conventional administration methods.
Oragenics has also pursued ONP-001, an intranasal product candidate for glioblastoma, an aggressive form of brain cancer.
Further Reading
- Five stocks we like better than Oragenics
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.
